The ReCoDe addiction research consortium: Losing and regaining control over drug intake—Findings and future perspectives

IF 3.1 3区 医学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Rainer Spanagel, Patrick Bach, Tobias Banaschewski, Anne Beck, Felix Bermpohl, Rick E. Bernardi, Christian Beste, Lorenz Deserno, Daniel Durstewitz, Ulrich Ebner-Priemer, Tanja Endrass, Karen D. Ersche, Gordon Feld, Martin Fungisai Gerchen, Björn Gerlach, Thomas Goschke, Anita Christiane Hansson, Christine Heim, Stefan Kiebel, Falk Kiefer, Peter Kirsch, Clemens Kirschbaum, Georgia Koppe, Bernd Lenz, Shuyan Liu, Michael Marxen, Marcus W. Meinhardt, Andreas Meyer-Lindenberg, Christiane Montag, Christian P. Müller, Wolfgang E. Nagel, Ana M. M. Oliveria, David Owald, Maximilian Pilhatsch, Josef Priller, Michael A. Rapp, Markus Reichert, Stephan Ripke, Kerstin Ritter, Nina Romanczuk-Seiferth, Florian Schlagenhauf, Emanuel Schwarz, Sarah Schwöbel, Michael N. Smolka, Surjo R. Soekadar, Wolfgang H. Sommer, Ann-Kathrin Stock, Andreas Ströhle, Heike Tost, Sabine Vollstädt-Klein, Henrik Walter, Tina Waschke, Stephanie H. Witt, Andreas Heinz, Other members of the ReCoDe Consortium
{"title":"The ReCoDe addiction research consortium: Losing and regaining control over drug intake—Findings and future perspectives","authors":"Rainer Spanagel,&nbsp;Patrick Bach,&nbsp;Tobias Banaschewski,&nbsp;Anne Beck,&nbsp;Felix Bermpohl,&nbsp;Rick E. Bernardi,&nbsp;Christian Beste,&nbsp;Lorenz Deserno,&nbsp;Daniel Durstewitz,&nbsp;Ulrich Ebner-Priemer,&nbsp;Tanja Endrass,&nbsp;Karen D. Ersche,&nbsp;Gordon Feld,&nbsp;Martin Fungisai Gerchen,&nbsp;Björn Gerlach,&nbsp;Thomas Goschke,&nbsp;Anita Christiane Hansson,&nbsp;Christine Heim,&nbsp;Stefan Kiebel,&nbsp;Falk Kiefer,&nbsp;Peter Kirsch,&nbsp;Clemens Kirschbaum,&nbsp;Georgia Koppe,&nbsp;Bernd Lenz,&nbsp;Shuyan Liu,&nbsp;Michael Marxen,&nbsp;Marcus W. Meinhardt,&nbsp;Andreas Meyer-Lindenberg,&nbsp;Christiane Montag,&nbsp;Christian P. Müller,&nbsp;Wolfgang E. Nagel,&nbsp;Ana M. M. Oliveria,&nbsp;David Owald,&nbsp;Maximilian Pilhatsch,&nbsp;Josef Priller,&nbsp;Michael A. Rapp,&nbsp;Markus Reichert,&nbsp;Stephan Ripke,&nbsp;Kerstin Ritter,&nbsp;Nina Romanczuk-Seiferth,&nbsp;Florian Schlagenhauf,&nbsp;Emanuel Schwarz,&nbsp;Sarah Schwöbel,&nbsp;Michael N. Smolka,&nbsp;Surjo R. Soekadar,&nbsp;Wolfgang H. Sommer,&nbsp;Ann-Kathrin Stock,&nbsp;Andreas Ströhle,&nbsp;Heike Tost,&nbsp;Sabine Vollstädt-Klein,&nbsp;Henrik Walter,&nbsp;Tina Waschke,&nbsp;Stephanie H. Witt,&nbsp;Andreas Heinz,&nbsp;Other members of the ReCoDe Consortium","doi":"10.1111/adb.13419","DOIUrl":null,"url":null,"abstract":"<p>Substance use disorders (SUDs) are seen as a continuum ranging from goal-directed and hedonic drug use to loss of control over drug intake with aversive consequences for mental and physical health and social functioning. The main goals of our interdisciplinary German collaborative research centre on <i>Losing and Regaining Control over Drug Intake</i> (ReCoDe) are (i) to study triggers (drug cues, stressors, drug priming) and modifying factors (age, gender, physical activity, cognitive functions, childhood adversity, social factors, such as loneliness and social contact/interaction) that longitudinally modulate the trajectories of losing and regaining control over drug consumption under real-life conditions. (ii) To study underlying behavioural, cognitive and neurobiological mechanisms of disease trajectories and drug-related behaviours and (iii) to provide non-invasive mechanism-based interventions. These goals are achieved by: (A) using innovative mHealth (mobile health) tools to longitudinally monitor the effects of triggers and modifying factors on drug consumption patterns in real life in a cohort of 900 patients with alcohol use disorder. This approach will be complemented by animal models of addiction with 24/7 automated behavioural monitoring across an entire disease trajectory; i.e. from a naïve state to a drug-taking state to an addiction or resilience-like state. (B) The identification and, if applicable, computational modelling of key molecular, neurobiological and psychological mechanisms (e.g., reduced cognitive flexibility) mediating the effects of such triggers and modifying factors on disease trajectories. (C) Developing and testing non-invasive interventions (e.g., Just-In-Time-Adaptive-Interventions (JITAIs), various non-invasive brain stimulations (NIBS), individualized physical activity) that specifically target the underlying mechanisms for regaining control over drug intake. Here, we will report on the most important results of the first funding period and outline our future research strategy.</p>","PeriodicalId":7289,"journal":{"name":"Addiction Biology","volume":"29 7","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/adb.13419","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction Biology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/adb.13419","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Substance use disorders (SUDs) are seen as a continuum ranging from goal-directed and hedonic drug use to loss of control over drug intake with aversive consequences for mental and physical health and social functioning. The main goals of our interdisciplinary German collaborative research centre on Losing and Regaining Control over Drug Intake (ReCoDe) are (i) to study triggers (drug cues, stressors, drug priming) and modifying factors (age, gender, physical activity, cognitive functions, childhood adversity, social factors, such as loneliness and social contact/interaction) that longitudinally modulate the trajectories of losing and regaining control over drug consumption under real-life conditions. (ii) To study underlying behavioural, cognitive and neurobiological mechanisms of disease trajectories and drug-related behaviours and (iii) to provide non-invasive mechanism-based interventions. These goals are achieved by: (A) using innovative mHealth (mobile health) tools to longitudinally monitor the effects of triggers and modifying factors on drug consumption patterns in real life in a cohort of 900 patients with alcohol use disorder. This approach will be complemented by animal models of addiction with 24/7 automated behavioural monitoring across an entire disease trajectory; i.e. from a naïve state to a drug-taking state to an addiction or resilience-like state. (B) The identification and, if applicable, computational modelling of key molecular, neurobiological and psychological mechanisms (e.g., reduced cognitive flexibility) mediating the effects of such triggers and modifying factors on disease trajectories. (C) Developing and testing non-invasive interventions (e.g., Just-In-Time-Adaptive-Interventions (JITAIs), various non-invasive brain stimulations (NIBS), individualized physical activity) that specifically target the underlying mechanisms for regaining control over drug intake. Here, we will report on the most important results of the first funding period and outline our future research strategy.

Abstract Image

ReCoDe成瘾研究联盟:失去和重新获得对药物摄入的控制--研究结果和未来展望。
药物使用失调症(SUDs)被视为一个连续统一体,其范围从目标导向型和享乐型药物使用,到对药物摄入失去控制并对身心健康和社会功能造成厌恶性后果。我们的德国跨学科合作研究中心 "失去和重新获得对药物摄入的控制"(ReCoDe)的主要目标是:(i) 研究在现实生活条件下纵向调节失去和重新获得对药物摄入控制的轨迹的触发因素(药物线索、压力源、药物引物)和调节因素(年龄、性别、体育活动、认知功能、童年逆境、社会因素,如孤独和社会接触/互动)。(ii) 研究疾病轨迹和毒品相关行为的潜在行为、认知和神经生物学机制,以及 (iii) 提供基于机制的非侵入性干预措施。通过以下方式实现这些目标(A) 使用创新的移动保健(mHealth)工具,在 900 名酒精使用障碍患者的队列中,纵向监测现实生活中诱发和改变因素对药物消费模式的影响。这种方法将得到成瘾动物模型的补充,对整个疾病轨迹进行全天候自动行为监测,即从天真状态到吸毒状态再到成瘾或类似复原状态。(B) 确定并在适用情况下,对介导这些诱因和改变因素对疾病轨迹影响的关键分子、神经生物学和心理机制(如认知灵活性降低)进行计算建模。(C) 开发和测试非侵入性干预措施(如适时适应干预(JITAIs)、各种非侵入性脑部刺激(NIBS)、个性化体育活动),专门针对重新控制药物摄入量的潜在机制。在此,我们将报告第一个资助期取得的最重要成果,并概述我们未来的研究战略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Addiction Biology
Addiction Biology 生物-生化与分子生物学
CiteScore
8.10
自引率
2.90%
发文量
118
审稿时长
6-12 weeks
期刊介绍: Addiction Biology is focused on neuroscience contributions and it aims to advance our understanding of the action of drugs of abuse and addictive processes. Papers are accepted in both animal experimentation or clinical research. The content is geared towards behavioral, molecular, genetic, biochemical, neuro-biological and pharmacology aspects of these fields. Addiction Biology includes peer-reviewed original research reports and reviews. Addiction Biology is published on behalf of the Society for the Study of Addiction to Alcohol and other Drugs (SSA). Members of the Society for the Study of Addiction receive the Journal as part of their annual membership subscription.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信